郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Complex action of tyramine, tryptamine and histamine on native and recombinant ASICs.

期刊:Channels (Austin, Tex.)发表年份:2017作者:Oleg I Barygin; Margarita S Komarova; Tatyana B Tikhonova; Anastasiia S Korosteleva; Maxim V Nikolaev; Lev G Magazanik; Denis B Tikhonov

药效评价Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.

期刊:The Biochemical journal发表年份:2017作者:William Nolan; Harriet McHale-Owen; Clive Bate

药效评价FTBMT, a Novel and Selective GPR52 Agonist, Demonstrates Antipsychotic-Like and Procognitive Effects in Rodents, Revealing a Potential Therapeutic Agent for Schizophrenia.

期刊:The Journal of pharmacology and experimental therapeutics发表年份:2017作者:Keiji Nishiyama; Hirobumi Suzuki; Toshiya Harasawa; Noriko Suzuki; Emi Kurimoto; Takayuki Kawai; Minoru Maruyama; Hidetoshi Komatsu; Kensuke Sakuma; Yuji Shimizu; Masato Shimojo

药效评价Partial Agonist and Biased Signaling Properties of the Synthetic Enantiomers J113863/UCB35625 at Chemokine Receptors CCR2 and CCR5.

期刊:The Journal of biological chemistry发表年份:2017作者:Jenny Corbisier; Alexandre Huszagh; Céline Galés; Marc Parmentier; Jean-Yves Springael